This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wright, C. F. Articles by Oswald, B. W. Search for Related Content PubMed PubMed Citation Articles by Wright, C. F. Articles by Oswald, B. W.

 Previous Article  |  Next Article 

J Virol, February 1998, p. 1446-1451, Vol. 72, No. 2
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

A Vaccinia Virus Late Transcription Factor Copurifies with a Factor That Binds to a Viral Late Promoter and Is Complemented by Extracts from Uninfected HeLa Cells

Cynthia F. Wright,^1,* Alan E. Hubbs,² Sajeevani K. Gunasinghe,¹ and Betty W. Oswald¹

Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, and Department of Cellular Pathology, Armed Forces Institute of Pathology, Washington, D.C. 20306-6000

Received 4 August 1997/Accepted 29 October 1997

We have previously described a vaccinia virus late transcription factor, VLTF-X, which we found to be present in cells at early and late times in infection. In this study, transcription complementation assays were used to demonstrate that VLTF-X activity is also present in virion extracts and in the cytoplasm of uninfected HeLa cells. Mobility shift assays performed on various VLTF-X preparations revealed that a late promoter DNA-binding activity cochromatographed and cosedimented with VLTF-X activity. Competition experiments demonstrated that this binding was specific for the late promoter region of the probe and that late transcription was dramatically reduced by an oligonucleotide that blocked factor-DNA complex formation but was only minimally affected by an oligonucleotide that did not inhibit complex formation. These results suggest that a cellular factor may participate in vaccinia virus late transcription. These findings also confirm the requirement for VLTF-X and distinguish it from any of the previously described vaccinia virus late transcription factors, which have all been mapped to the viral genome. Finally, these studies also suggest that the biochemical role for VLTF-X may be in late promoter recognition.

---

^* Corresponding author. Mailing address: Department of Pathology and Laboratory Medicine, Medical University of South Carolina, 171 Ashley Ave., Charleston, SC 29425. Phone: (803) 792-6658. Fax: (803) 792-7762. E-mail: wrightcf{at}musc.edu.

This article has been cited by other articles:

• Broyles, S. S. (2003). Vaccinia virus transcription. J. Gen. Virol. 84: 2293-2303 [Abstract] [Full Text]  
• Lackner, C. A., Condit, R. C. (2000). Vaccinia Virus Gene A18R DNA Helicase Is a Transcript Release Factor. J. Biol. Chem. 275: 1485-1494 [Abstract] [Full Text]  
• Gunasinghe, S. K., Hubbs, A. E., Wright, C. F. (1998). A Vaccinia Virus Late Transcription Factor with Biochemical and Molecular Identity to a Human Cellular Protein. J. Biol. Chem. 273: 27524-27530 [Abstract] [Full Text]  
• Xiang, Y., Simpson, D. A., Spiegel, J., Zhou, A., Silverman, R. H., Condit, R. C. (1998). The Vaccinia Virus A18R DNA Helicase Is a Postreplicative Negative Transcription Elongation Factor. J. Virol. 72: 7012-7023 [Abstract] [Full Text]  
• Sanz, P., Moss, B. (1998). A New Vaccinia Virus Intermediate Transcription Factor. J. Virol. 72: 6880-6883 [Abstract] [Full Text]  
• Wright, C. F., Oswald, B. W., Dellis, S. (2001). Vaccinia Virus Late Transcription Is Activated in Vitro by Cellular Heterogeneous Nuclear Ribonucleoproteins. J. Biol. Chem. 276: 40680-40686 [Abstract] [Full Text]